• Passa al contenuto principale
BC

biochimica clinica

it_IT Italian
it_IT Italian en_US English
  • Home
  • Casi clinici
  • Ahead of print e Ultimo Fascicolo - Accedi per visualizzare gli articoli
  • Archivio BC fino a 2024
  • Sottometti un articolo
  • Norme Autori
  • Cerca

CONTRIBUTI SCIENTIFICI – Scientific Papers

Volume:

Biochimica Clinica 2015; 39(3) 184-187

Pubblicato on-line:

DOI:

Scarica in PDF:

Accertamenti tossicologici su sangue a seguito dell’applicazione dell’articolo 187 del Codice della Strada: uno studio retrospettivo nei territori di Milano e provincia

AUTORI

Adriano Masarin, Cecilia Gechtman, Stefania Paccagnini, Giovanni Pietro Gesu
Laboratorio di Analisi Chimico Cliniche e Microbiologia, Dipartimento di Medicina di Laboratorio, Azienda Ospedaliera Niguarda Ca’ Granda, Milano

ABSTRACT

In Italy driving under the influence of drug of abuse (DRUID) is prosecuted since 1992. Controls are performed according to a two-step procedure: blood immunoscreening followed, in case of result positivity, by confirmation using a separative technique coupled to mass spectrometry. This study reports a two-year (2012-2014) retrospective review of blood analyses performed in this framework in our hospital. Over this period, 1384 subjects [1170 (84.5%) were male, mean age 36.7 years] were controlled on request by the authorities of Traffic Police. 426 subjects (30,7%) were found positive to at least one drug. Among them, 212 were positive for cannabis, 150 for cocaine and its metabolites, 24 for opiates, 16 for methadone and 9 for amphetamine-type stimulants. Out of the 212 subjects tested positive for cannabis, 141 had detectable levels of ????-9-tetrahydrocannabinol (THC) for engaging prosecution against the drivers. Blood THC concentrations were in the range between 2 38 μg/L. Our results clearly illustrate the huge prominence of cannabis among substances involved in DRUID. According to our data, 9.9% of drivers found positive for cannabis and cocaine metabolites, probably no longer under the influence of drug of abuse at time they were driving, should be submitted to other investigations (e.g., on hair).

BIBLIOGRAFIA

HOME
PRIVACY POLICY
5x1000 Docemus

LOGO SIBioC

EDITORE RESPONSABILE
Alberto Oliaro

EDITORIAL SECRETARY
Edizioni Minerva Medica S.p.A.
Corso Bramante 83-85, 10126 Torino
T +39 011 678282
journals.dept@minervamedica.it

Designed by Biomedia srl
© 2025 SIBioC
P. IVA IT 06484860967